Cryoport Executive and Leadership Team

Jerrell Shelton, the Chief Executive Officer at Cryoport, directs the overarching corporate strategy and long-term vision. Shelton guides the company's expansion into new markets and ensures alignment with the evolving needs of the life sciences sector, particularly in cell and gene therapies. This leadership involves fostering key partnerships and driving initiatives that solidify Cryoport's position as a global leader in temperature-controlled logistics. The focus remains on enhancing the company's comprehensive platform of advanced packaging, specialty logistics, and biostorage solutions. Shelton's strategic direction ensures operational excellence and sustained growth across all business units. By championing innovation, Jerrell Shelton propels Cryoport's mission to support critical biopharmaceutical and research endeavors worldwide, maintaining the highest standards of service and reliability in a highly regulated industry.

Mark Sawicki, the President & Chief Executive Officer at Cryoport, spearheads the company's global operational execution and strategic market penetration. Sawicki oversees the integration of advanced packaging, specialty logistics, and biostorage services, ensuring seamless delivery for the cell and gene therapy market. This role involves driving technological advancements in cryogenic equipment and informatics to meet stringent temperature-control requirements. Sawicki's leadership ensures that Cryoport maintains its status as a premier life science-focused specialty courier, supporting biopharmaceutical companies, research institutions, and universities. The executive's focus is on optimizing the supply chain for critical biological materials, thereby accelerating therapeutic development and patient access. Through strategic oversight, Mark Sawicki reinforces Cryoport's commitment to providing reliable, end-to-end solutions that address complex logistical challenges in the global life sciences arena.

Phillip Wilson, the Chief Operating Officer at Cryoport, manages the day-to-day operational efficiency and scalability of the company's global supply chain network. Wilson directs the execution of advanced packaging, specialty logistics, and biostorage services, ensuring adherence to the highest quality and regulatory standards. This leadership involves optimizing the deployment of cryogenic equipment and informatics solutions to support the unique demands of the cell and gene therapy market. The Chief Operating Officer's responsibilities extend to enhancing service delivery for biopharmaceutical companies, research institutions, and universities worldwide. Phillip Wilson focuses on streamlining processes and implementing best practices to maintain Cryoport's competitive edge in temperature-controlled logistics. By overseeing critical operational functions, Wilson ensures the reliable transport and storage of sensitive biological materials, directly contributing to the advancement of global health initiatives.

Leonard Suelter, the Chief Technology Officer at Cryoport, architects the company's technological infrastructure and drives innovation in its service offerings. Suelter oversees the development and implementation of advanced informatics and cryogenic equipment, crucial for maintaining precise temperature control across the global supply chain. This leadership role is pivotal in supporting the specialized needs of the cell and gene therapy market, as well as broader biopharmaceutical and reproductive medicine sectors. The Chief Technology Officer's focus includes enhancing the capabilities of Cryoport's comprehensive platform, ensuring data integrity and operational security. Leonard Suelter guides the integration of cutting-edge technologies to improve efficiency, reliability, and traceability for clients worldwide. By leading technological advancements, Suelter reinforces Cryoport's commitment to providing state-of-the-art solutions for the most sensitive biological materials.